01/19/2015
Analytical Methods for biomarkers Anti-IIa, Anti-Xa and TPFI

Anapharm Biotech, the peptide and protein chemistry division of Anapharm Europe, has completed method development of biomarkers Anti-IIa, Anti-Xa and TPFI in human plasma by chromogenic assays and ELISA, respectively. The determination of these biomarkers are relevant for the performance of clinical trials with Low Molecular Weight Heparins.
MORE NEWS
Peptides Series: Understanding Therapeutic Peptides
Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.
The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics
Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.
Overcoming Matrix Effects in the Analysis of Lipophilic Compounds
At the 10th EBF Young Scientist Symposium, we highlighted the complexities of analysing Fucoxanthin derivatives and demonstrated how innovative approaches, such as 2D Chromatography, can overcome these obstacles.